Chief Medical Officer Summit 360º Agenda 2026 Page 1

Day 1: Monday, April 13, 2026

List/Print View

Grid View

Showing Events in 1 Track from 07:30am to 08:10am

Registration

7:30AM - 8:10AM

Registration Opens

Showing Events in 1 Track from 08:10am to 08:20am

Co-Chairs Opening Remarks

8:10AM - 8:20AM

Co-Chairs Opening Remarks

Co-Chairs:

Anna Frostegård, MD, PhD, Co-Founder, Chief Scientific & Medical Officer, Annexin Pharmaceuticals

Jeff Humphrey, MD, CMO, Myris Therapeutics

Showing Events in 1 Track from 08:20am to 09:00am

Annual Keynote

8:20AM - 9:00AM

Annual Keynote Address on the State of the Drug Development Industry

Speaker:

Kenneth Getz, MBA, Director and Professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine

Showing Events in 1 Track from 09:00am to 09:25am

CEO Keynote Discussion

9:00AM - 9:25AM

CEO Keynote Fireside on the Growth of Insmed

Speaker:

William Lewis, CEO, Insmed, Inc.

Moderated with:

Ravi Rao, MD, BChir, PhD, CMO, Sitryx

Showing Events in 1 Track from 09:25am to 09:45am

Patient Keynote

9:25AM - 9:45AM

Patient Keynote: Collaborating to Advance Drug Development

Speaker:

Kristin Smedley, Founder, CEO, Curing Retinal Blindness Foundation

Showing Events in 1 Track from 09:45am to 10:00am

Morning General Session

9:45AM - 10:00AM

Reframing the IND: From Tactical Requirement to Strategic Opportunity

Speaker:

Michael Murphy, MD, PhD, CMO / CSO, Worldwide Clinical Trials

Showing Events in 1 Track from 10:00am to 11:20am

Grand Opening Break & Networking

10:00AM - 11:20AM

Grand Opening Break & Networking

Showing Events in 1 Track from 11:20am to 12:35pm

Morning General Session Continued

11:20AM - 11:50AM

Navigating a Rapidly Evolving Regulatory Environment

Speaker:

Peter Francis, MD, PhD, CMO & CSO, Ray Therapeutics

11:50AM - 12:05PM

Rescue Trials Succeed When …

Speaker:

Julie Martin, MSc, MBA, President & CEO, Scimega Research

12:05PM - 12:35PM

Establishing a New Paradigm in Biotech-Academia Partnerships

Speakers:

Giovanni Abbadessa, MD, PhD, Chief Medical Officer, ModeX Therapeutics

Steven Katz, MD, CMO and SVP, Translational Research, Shinobi Therapeutics

Showing Events in 1 Track from 12:35pm to 01:55pm

Lunch

12:35PM - 1:55PM

Lunch

Showing Events in 2 Tracks from 02:00pm to 03:30pm

New Technology & Adaptive Approaches

2:00PM - 2:30PM

AI Case Study Quickfire Presentations

2:30PM - 3:00PM

Practical Approaches to Leveraging AI in Clinical Development

Moderated by:

Nushmia Khokhar, MD, CMO, Oncology, Biohaven

Panelists:

Scott Chetham, PhD, CEO and Co-Founder, Faro Health

Gavin Corcoran, MD, FACP, Chief Development Officer, Formation Bio

3:00PM - 3:30PM

Accelerating Clinical Development with Adaptive Trial Approaches

Speakers:

Scott Harris, MD, Senior Strategic Advisor, Altimmune

Amy Simon, MD, CMO, Beam Therapeutics

Global Clinical Trials

Chair:

Barbara Wirostko, MD, CMO & Co-Founder, Qlaris Bio

2:00PM - 2:30PM

Global Clinical Trials Quickfire Presentations

2:30PM - 3:00PM

Developing a Global Clinical Trial Strategy

Moderated by:

Albert Kim, MD, PhD, Venture Partner, RA Ventures, President and CMO, Blackbird Development Team

Panelists:

Andrew Dietz, MD, VP, Head of Clinical Research & Development, Ensoma

Oliver Rosen, MD, Chief Medical Officer, Akamis Bio

3:00PM - 3:30PM

Partnering with Chinese Biotechs

Speakers:

Yaping Shou, MD, PhD, Founder & CEO, Wells Therapeutics

Andrea Wang-Gillam, MD, PhD, CMO, Global Head of R&D, Jacobio Pharmaceuticals

Showing Events in 1 Track from 03:30pm to 03:55pm

Afternoon Break & Networking

3:30PM - 3:55PM

Afternoon Break & Networking

Showing Events in 2 Tracks from 04:00pm to 05:30pm

Cross Functional Leadership

Chair:

Anna Frostegård, MD, PhD, Co-Founder, Chief Scientific & Medical Officer, Annexin Pharmaceuticals

4:00PM - 4:30PM

Managing CEO and Board Relationships

Panelists:

Donna Higgins, CEO, The Higgins Group

Joanne Lager, MD, CMO, Genetix Biotherapeutics

Barbara Troupin, MD, MBA, Fractional CMO, Laguna Bio & Others

4:30PM - 5:00PM

Integrating Commercialization Throughout the Drug Development Lifecycle

Moderator:

Raymond Urbanski, MD, PhD, CMO, Biotheryx

Panelists:

Patrick Burnett, MD, PhD, EVP, CMO, Arcutis Biotherapeutics

James “Terry" Ferguson, MD, CMO, Cadrenal Therapeutics

5:00PM - 5:30PM

Human and Technological Solutions to Ensure Effective and Efficient Clinical Operations

Panelists:

Dan Karlin, MD, CMO, MindMed

Jin Kim, CEO & Founder, Miracle

Team Building & Outsourcing

Chair:

Steve Zelenkofske, DO, President/Principal, SLZ Consulting

4:00PM - 4:30PM

Building Out CMO Teams

Moderator:

Seemi Khan, MD, MPH, MBA, Chief Development & Strategy Officer, Alkeus Pharmaceuticals

Panelists:

James Lewis, Executive Director, Barrington James

Holly Schachner, MD, CMO, 3DC, Deerfield Management

4:30PM - 5:00PM

How Outsourcing Partners Can Support Biotech Companies in a Financially Constrained Environment

Moderator:

Roger Waltzman, MD, MBA, CMO, Indaptus Therapeutics

Panelists:

Murray Abramson, MD, MPH, Chief Development Officer, Ascidian Therapeutics

Jay Destino, VP, FSP Solutions, BioPoint, Inc.

5:00PM - 5:30PM

Managing and Motivating a Team in a Challenging Time

Moderators:

Sarah Gheuens, MD, PhD, MMSc, CMO, Head of R&D, Agios Pharmaceuticals

Panelists:

Joseph Elassal, MD, MBA, CMO, Ankyra Therapeutics

Tanya Fischer, MD, PhD, CMO, Tenvie Therapeutics

Showing Events in 1 Track from 05:30pm to 06:30pm

Networking Reception

5:30PM - 6:30PM

Networking Reception

Day 1

Monday, April 13, 2026

Day 2

Tuesday, April 14, 2026

Day 1

Day 2

Subscribe for More Information